Mental health is no longer a hush-hush topic. More and more people are opening up about their mental health struggles, whether it's depression, anxiety, panic attacks, or obsessive thoughts. And as ...

Add Yahoo as a preferred source to see more of our stories on Google. In the first directive since his nomination to secretary of health and human services, Robert F. Kennedy Jr. thrust psychiatric ...

Add Yahoo as a preferred source to see more of our stories on Google. Immediately following Robert F. Kennedy Jr.’s confirmation as health secretary, President Donald Trump instructed his ...

Even though depression is one of the most common conditions in the world, and we know many of the things that increase the chances of getting it (e.g., early life stress, being female, serious medical ...

Antidepressants can be an important tool for treating symptoms of depression, but they don't work right away. Most antidepressants don't provide instant relief of symptoms related to depression, ...

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are two of the most common types of medications used to treat conditions such as depression, ...

This is the first installment in a series of articles about the science of various aspects of college life. Use of selective serotonin reuptake inhibitors, or SSRIs, has increased among college ...

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake ...

In the first directive since his nomination to secretary of health and human services, Robert F. Kennedy Jr. thrust psychiatric medications and their use among children into the national spotlight.

Immediately following Robert F. Kennedy Jr.'s confirmation as health secretary, President Donald Trump instructed his administration to assess the "threat" posed to children by the prescription of ...

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake ...